Some patients with imminently fatal cancer still receive treatment
(American Cancer Society) Patients who died within one month of being newly diagnosed with metastatic cancer in the United States received ineffective surgery, chemotherapy, radiation, and hormonal therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

NICE rules against new hormone therapy combo for breast cancer
Draft guidance on ribociclib with fluvestrant under consultation Related items fromOnMedica NICE rejects adjuvant use of breast cancer drug Breast cancer deaths down due to screening and new therapies New breast cancer drug ‘unaffordable’ for NHS Red tape delaying availability of new cancer drugs One in 10 children in phase I cancer trials respond to drugs (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 10, 2019 Category: UK Health Source Type: news

Estrogen and Cognition: An Enigma in Postmenopausal Women Estrogen and Cognition: An Enigma in Postmenopausal Women
Does hormone therapy improve cognition in women after menopause? Dr JoAnn Manson highlights the latest data and what it means for clinical practice.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2019 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Estrogen therapy boosts transgender women's brains
A new study from collaborating researchers in Brazil and Canada found that when trans women were on hormone therapy, they had better connections between important brain regions. (Source: the Mail online | Health)
Source: the Mail online | Health - March 26, 2019 Category: Consumer Health News Source Type: news

Endometriosis Awareness Month
March is Endometriosis Awareness Month.  Endometriosis is a painful condition where endometrial tissue grows outside the uterus. It is estimated that up to 10% of women have endometriosis (Ozkan 2008).   Endometriosis can cause infertility and for women with subfertility the prevalence rate ranges from 25% to 40% (Ozkan 2008). Endometriosis frequently presents with the symptom of pain (Barlow 1993) including dysmenorrhoea (painful periods), dyspareunia (pain during sexual intercourse), and pelvic or abdominal pain.  We invited Edgardo Somigliana, MD-PhD (Dept Clinical Sciences and Community Health, Universit...
Source: Cochrane News and Events - March 22, 2019 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Study links perimenopause to accelerated fat mass gains, lean mass losses
FINDINGSThe menopause transition, also known as perimenopause, is the time in a woman ’s life when hormonal changes lead to irregular menstruation, hot flashes and other symptoms leading up to menopause, when menstruation stops altogether. The researchers found that women undergoing perimenopause lost lean body mass and more than doubled their fat mass. The women’s lean and fat mass remained stable after the transition to menopause. The researchers also noted ethnic/racial differences in the impact of menopause on body composition.BACKGROUNDThe relationship between menopause and changes in body composition...
Source: UCLA Newsroom: Health Sciences - March 20, 2019 Category: Universities & Medical Training Source Type: news

Hormonal Therapy for Prostate Cancer Might Raise Depression Risk
Title: Hormonal Therapy for Prostate Cancer Might Raise Depression RiskCategory: Health NewsCreated: 3/19/2019 12:00:00 AMLast Editorial Review: 3/20/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 20, 2019 Category: Cancer & Oncology Source Type: news

Hormonal Therapy for Prostate Cancer Might Raise Depression Risk
TUESDAY, March 19, 2019 -- Hormonal treatment can help control prostate cancer but may increase a man's risk of depression, a new study by Danish researchers suggests. Male hormones, such as testosterone, are known to fuel the growth of prostate... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 19, 2019 Category: General Medicine Source Type: news

Test Predicts Resistance to Hormonal Therapy in Prostate Cancer
(MedPage Today) -- Validation study confirms assist in decision-making (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 16, 2019 Category: Hematology Source Type: news

Molecular 'Clues' May Predict Breast Cancer Return
If doctors could better predict which patients had a high recurrence risk, those women might want to continue hormone therapy past the standard five years. (Source: WebMD Health)
Source: WebMD Health - March 13, 2019 Category: Consumer Health News Source Type: news

SUSTAIN 9 Trial Success; Hormone Therapy & Alzheimer's;'Diabulimia '
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 8, 2019 Category: Psychiatry Source Type: news

Hormone Therapy Linked to Slight Rise in Alzheimer's Risk
Title: Hormone Therapy Linked to Slight Rise in Alzheimer's RiskCategory: Health NewsCreated: 3/7/2019 12:00:00 AMLast Editorial Review: 3/8/2019 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - March 8, 2019 Category: OBGYN Source Type: news

HRT Linked to Slight Rise in Alzheimer's Risk
The study found that women taking hormone replacement therapy had a 9 percent to 17 percent higher risk of developing Alzheimer's disease. In women who began taking hormone therapy before age 60, this increased risk was tied to use of HRT for a decade or longer. (Source: WebMD Health)
Source: WebMD Health - March 7, 2019 Category: Consumer Health News Source Type: news

Hormone Therapy Linked to Slight Rise in Alzheimer's Risk
THURSDAY, March 7, 2019 -- Many women turn to hormone therapy to ease some of the more troubling symptoms of menopause, such as hot flashes and night sweats. But new research suggests that relief may come at a cost -- an increased risk of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 7, 2019 Category: General Medicine Source Type: news

Long-Term Systemic Hormone Therapy May Up Alzheimer Risk
THURSDAY, March 7, 2019 -- Long-term use of systemic hormone therapy may be associated with an increased risk for Alzheimer disease, according to a study published online March 6 in The BMJ. Hanna Savolainen-Peltonen, M.D., Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 7, 2019 Category: Pharmaceuticals Source Type: news

VA study evaluates quality indicators for hormone therapy in menopausal women
(Wolters Kluwer Health) Improvements are needed in VA's prescribing of hormone therapy for menopausal women veterans, concludes a study in the Journal for Healthcare Quality, the peer-reviewed journal of the National Association for Healthcare Quality. The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 7, 2019 Category: International Medicine & Public Health Source Type: news

Vitamin D levels unaffected by hormone therapy in transgender adults
Research, published inThe Journal of Clinical Endocrinology& Metabolism, suggests that hormone therapy does not affect vitamin D levels in transgender adults. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 27, 2019 Category: Endocrinology Source Type: news

This African shrub shows remarkable anticancer potential
(Natural News) Cancer is a disease that strikes fear in a person’s heart, and for good reason. In 2018, the World Health Organization attributed more than 9.6 million deaths to this disease, making it the second leading cause of mortality in the world. While conventional treatments like chemotherapy, radiotherapy, and hormone therapy exist, these tend to do more harm than... (Source: NaturalNews.com)
Source: NaturalNews.com - February 24, 2019 Category: Consumer Health News Source Type: news

Hormone Therapy Linked to CV Risk During Gender Transition Hormone Therapy Linked to CV Risk During Gender Transition
Transgender hormone therapy is associated with an increased risk for MI, stroke, and venous thromboembolism, underscoring the importance of patient counseling and close monitoring in this population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 20, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Increase stroke risk in transgender women receiving hormone therapy
Research, published inCirculation, suggests that hormone therapy increases the risk of stroke in transgender women.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 20, 2019 Category: Endocrinology Source Type: news

Cardiovascular Risk Increased During Gender Transition
TUESDAY, Feb. 19, 2019 -- People receiving hormone therapy during gender transition have an increased risk for cardiovascular events, according to a study published online Feb. 18 in Circulation. Nienke M. Nota, M.D., from Vrije Universiteit... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 19, 2019 Category: Pharmaceuticals Source Type: news

Transgender people taking hormone therapy may be at TWICE the risk of heart attack
Being transgender carries all manner of social and health risks. Transitioning can drastically improve quality of life, but the necessary hormones raise heart risks, a University of Amsterdam study found. (Source: the Mail online | Health)
Source: the Mail online | Health - February 18, 2019 Category: Consumer Health News Source Type: news

Gender transition hormone therapy may increase cardiovascular risk, study says
Transgendered people who've undergone hormone therapy may be at an elevated risk for cardiovascular events, a new study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 18, 2019 Category: Consumer Health News Source Type: news

Medical News Today: What to expect from Lupron treatment
Lupron (leuprolide acetate) is a type of hormone therapy for people with prostate cancer. Lupron is an injection drug, and doctors often prescribe it in combination with radiation therapy or surgery. As it lowers a person ’s testosterone levels, Lupron can cause a range of side effects. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 18, 2019 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Medical News Today: Gender transition drugs could be bad for the heart
New research suggests that hormone therapy may place people who are gender transitioning at a higher risk of cardiovascular events. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 18, 2019 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Transgender Hormone Therapy Could Pose Heart Dangers
MONDAY, Feb. 18, 2019 -- Men and women who get hormone therapy during gender transition treatment may face a much higher risk for developing heart disease, new Dutch research cautions. " In light of our results, we urge both physicians and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 18, 2019 Category: General Medicine Source Type: news

Hormone therapy may increase cardiovascular risk during gender transition
(American Heart Association) People receiving hormone therapy during gender transition had an elevated risk for cardiovascular events, such as strokes, blood clots and heart attacks.Findings underscore the importance of counseling and close monitoring of transgender patients receiving hormone therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 18, 2019 Category: International Medicine & Public Health Source Type: news

Hooked on hormones: Once you get on hormone replacement drugs, it's dangerous to get off due to increased risk of cardiac arrest and stroke
(Natural News) Hormone replacement therapy (HRT), or simply hormone therapy (HT), is the only medical treatment that successfully minimizes the side effects of menopause, such as hot flashes and night sweats. It is also known to address other female problems such as vaginal dryness and uterine discomfort, as well as inhibit the production of estrogen... (Source: NaturalNews.com)
Source: NaturalNews.com - February 14, 2019 Category: Consumer Health News Source Type: news

Immunotherapy combination generates responses against castration-resistant metastatic prostate cancer
(University of Texas M. D. Anderson Cancer Center) Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at MD Anderson. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 14, 2019 Category: Cancer & Oncology Source Type: news

New Imaging Method Measures Efficacy of Breast Cancer Therapy
Researchers from the University of Wisconsin School of Medicine and Public Health have discovered a new way to measure the efficacy or failure of hormone therapy for breast cancer patients. A study detailing the findings was published in the February issue of The Journal of Nuclear Medicine. The findings showed that positron emission tomography (PET) imaging with 18F-fluorofuranylnorprogesterone (18F-FFNP) has been found to successfully measure changes in progesterone receptor (PR) levels resulting from a short-course estrogen treatment, also known as an estradiol challenge. Estrogen-receptor (ER)-positive breast cancer is...
Source: MDDI - February 12, 2019 Category: Medical Devices Authors: MDDI Staff Tags: Imaging Source Type: news

New machine learning method could spare some women from unnecessary breast surgery
(Dartmouth-Hitchcock Medical Center) Dartmouth researchers have developed and evaluated a machine learning approach of using patient core needle biopsy data to identify the risk that atypical ductal hyperplasia (ADH) breast lesions may upgrade to cancer. This knowledge can potentially help clinicians and low-risk patients decide whether active surveillance and hormonal therapy is a reasonable management approach. Using the method could spare patients with benign lesions from invasive surgeries while maintaining high sensitivity for predicting malignant lesions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2019 Category: International Medicine & Public Health Source Type: news

PET imaging agent may allow early measurement of efficacy of breast cancer therapy
(Society of Nuclear Medicine and Molecular Imaging) Physicians may soon have a new way to measure the efficacy of hormone therapy for breast cancer patients, according to research published in the February issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 11, 2019 Category: Cancer & Oncology Source Type: news

UCLA ’s Dennis Slamon awarded Sjöberg Prize for pioneering cancer research
Dr. Dennis Slamon, director of the Revlon/UCLA Women ’s Cancer Research Program, has been named a co-winner of the 2019 Sjöberg Prize by the Royal Swedish Academy of Sciences and Sweden’s Sjöberg Foundation. Honored for his groundbreaking research that led to the development of successful targeted cancer therapies, Slamon shares the award with D r. Brian Druker of Oregon Health& Science University.The Sj öberg Prize has been awarded annually since 2016 to recognize outstanding cancer research. The honor carries a prize of $1 million — $100,000 as award money and $900,000 to fund future ...
Source: UCLA Newsroom: Health Sciences - February 5, 2019 Category: Universities & Medical Training Source Type: news

Estrogen and Venous Thrombosis: Route, Type, and Dose Matter! Estrogen and Venous Thrombosis: Route, Type, and Dose Matter!
JoAnn Manson reviews a large study that provides evidence about the safety of different estrogen formulations for menopausal hormone therapy.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 1, 2019 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

‘Promising’ test could predict whether breast cancer will come back
Researchers at the University of Edinburgh studied tumour samples from women with breast cancer and found hormone therapy drugs aromatase inhibitors triggered tell-tale genetic changes. (Source: the Mail online | Health)
Source: the Mail online | Health - January 21, 2019 Category: Consumer Health News Source Type: news

Gene changes may predict breast cancer relapse, study suggests
(University of Edinburgh) Scientists at the University of Edinburgh have identified genetic changes that may predict the likelihood of breast cancer relapse in women taking a common type of hormone therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 21, 2019 Category: Cancer & Oncology Source Type: news

Menopause | Medscape Menopause | Medscape
Review in-depth clinical information, latest medical news, and guidelines on menopause and perimenopause, including managing hot flash symptoms and hormone therapy. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 17, 2019 Category: Consumer Health News Tags: Resource Center Source Type: news

Prevalence of Knee OA Lower With Menopausal Hormone Therapy
THURSDAY, Jan. 17, 2019 -- For postmenopausal women, the prevalence of knee osteoarthritis is lower with menopausal hormone therapy (MHT) use, according to a study published online Dec. 21 in Menopause. Jae Hyun Jung, M.D., Ph.D., from the Korea... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 17, 2019 Category: Pharmaceuticals Source Type: news

Menopausal Hormone Tx Use Down Post-WHI Recommendations
MONDAY, Jan. 14, 2019 -- The Women's Health Initiative (WHI) recommendations for menopausal hormone therapy (MHT) use issued in 2002 have been widely adopted, according to a study published online Dec. 21 in Menopause. Sybil L. Crawford, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 14, 2019 Category: Pharmaceuticals Source Type: news

Jan 11 2019 This Week in Cardiology Jan 11 2019 This Week in Cardiology
Appropriate use criteria for imaging, HRRP efficacy, medical marijuana, radiation exposure in the cath lab, and hormone therapy are the topics discussed this week ’ s podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 11, 2019 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Hormone Therapy May Protect Against Knee Osteoarthritis Hormone Therapy May Protect Against Knee Osteoarthritis
Postmenopausal women taking hormone therapy were significantly less likely to develop symptomatic knee osteoarthritis compared with those who did not take hormone therapy, a large study has found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 11, 2019 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Hormone therapy may lower the risk of knee osteoarthritis
Research, published inMenopause, suggests that women who receive hormone therapy have a lower risk of developing osteoarthritis.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 10, 2019 Category: Endocrinology Source Type: news

Hormone therapy may be best defense against knee osteoarthritis
(The North American Menopause Society (NAMS)) There is an ongoing debate regarding the relationship between knee osteoarthritis and hormone therapy (HT), with small-scale studies providing mixed results. A new large-scale study from Korea shows that women receiving HT had a significantly lower prevalence of symptomatic knee osteoarthritis compared with women who did not take hormones. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2019 Category: International Medicine & Public Health Source Type: news

Gender-Affirming Hormone Therapy Doesn't Lower BMD in Adults Gender-Affirming Hormone Therapy Doesn't Lower BMD in Adults
Gender-affirming hormone treatment (HT) does not weaken bones in adults with long-term use, according to a new study in hundreds of transgender men and women.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 5, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Gender-Affirming Hormone Therapy and the Risk of Tumors Gender-Affirming Hormone Therapy and the Risk of Tumors
Are transgender individuals receiving gender-affirming hormone therapy at a greater risk for developing hormone-dependent tumors?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 24, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Study claims some fertility treatments raise the risk of autism in children
(Natural News) For couples who cannot have children, fertility treatments could be heaven-sent. But according to a study by American and Swedish researchers, the said treatments may not be as seamless as they are made out to be, with progesterone hormone therapy, in particular, causing a rise in children who have autism. The researchers from... (Source: NaturalNews.com)
Source: NaturalNews.com - December 16, 2018 Category: Consumer Health News Source Type: news

Lower-Dose Tamoxifen Works As Well As High-Dose
New research shows that a lower dose of the hormone therapy Tamoxifen is as effective as the higher dose treatment in helping to prevent breast cancer from returning and guarding against new cancers in women who had high-risk breast tissue. (Source: WebMD Health)
Source: WebMD Health - December 6, 2018 Category: Consumer Health News Source Type: news

Targeted Drug Plus Hormone Therapy Stops Tumor Growth In Patients With Early Breast Cancer
A targeted cancer drug added to hormone therapy has been shown to stunt cancer growth in women with newly diagnosed breast cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 6, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: NASDAQ:PFE Source Type: news

Circulating tumor cell count could help choose treatment for metastatic breast cancer patients
(American Association for Cancer Research) Circulating tumor-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline treatment for patients with estrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast cancer, according to data from the phase III STIC CTC clinical trial presented at the 2018 San Antonio Breast Cancer Symposium. In the case of discrepancy between CTC count-based treatment choice and physician's choice of treatment, frontline chemotherapy was associated with a significant gain in overall survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Post-Op Radiation Plus Hormone Therapy May Boost Aggressive Prostate Cancer Outcomes Post-Op Radiation Plus Hormone Therapy May Boost Aggressive Prostate Cancer Outcomes
In patients with aggressive (Gleason score 9-10) prostate cancer, adjuvant radiation/hormone combination therapy before recurrence may improve survival, researchers say.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - November 27, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news